# Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis

> **NCT05073926** · — · RECRUITING · sponsor: **Region Skane** · enrollment: 100 (estimated)

## Conditions studied

- Latent Tuberculosis
- Staphylococcus Aureus

## Interventions

- **OTHER:** No intervention is part of the study protocol

## Key facts

- **NCT ID:** NCT05073926
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-30
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05073926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05073926, "Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05073926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*